(1 - 7 von 7
)
William Blair Downgrades Sequenom to Market Perform | GenomeWeb
www.genomeweb.com
Despite Sequenom's analyst day presentation, which focused on new NIPT and oncology products, the investment bank said there was still uncertainty in the...
MSA Safety initiated with a Market Perform at William Blair MSA - The...
thefly.com
William Blair analyst Lawrence De Maria started MSA Safety with a Market Perform rating Jan. MSA MSA Safety. $ (0.14%).
sortiert nach Relevanz / Datum